Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Consulting agrmnt
Director departure
Appointed director
|
|
ORAMED PHARMACEUTICALS INC. (ORMP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/31/2023 |
4
| KIDRON NADAV (President and CEO) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 120,000 shares
@ $0 |
|
| 05/31/2023 |
4
| Kidron Miriam (Chief Scientific Officer) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 53,500 shares
@ $0 |
|
| 05/31/2023 |
4
| Derovan Netanel (Chief Legal Officer) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 20,500 shares
@ $0 |
|
| 05/31/2023 |
4
| Hexter Joshua (COO & CBO) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 27,000 shares
@ $0 |
|
| 05/31/2023 |
4
| Silberman David (CFO) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 24,500 shares
@ $0 |
|
| 05/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2023 |
4
| Mayer Arie (Director) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Bought 5,009 shares
@ $2.22, valued at
$11.1k
Bought 3,800 shares
@ $2.21, valued at
$8.4k
|
|
| 03/16/2023 |
4
| KIDRON NADAV (President and CEO) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Bought 26,000 shares
@ $2.039, valued at
$53k
|
|
| 03/15/2023 |
4
| KIDRON NADAV (President and CEO) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Bought 100,000 shares
@ $2.01, valued at
$201k
|
|
| 03/15/2023 |
4
| Kidron Miriam (Chief Scientific Officer) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Sold 100,000 shares
@ $2.01, valued at
$201k
|
|
| 03/15/2023 |
4
| Rozov Yadin (Director) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Bought 20,000 shares
@ $1.956, valued at
$39.1k
Bought 50,000 shares
@ $2.049, valued at
$102.5k
|
|
| 01/04/2023 |
4
| Rabinowitz Michael (Chief Commercial Officer) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Sold 1,425 shares
@ $13.0132, valued at
$18.5k
Sold 11,900 shares
@ $12.4917, valued at
$148.7k
|
|
| 10/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2022 |
4
| Sank Leonard (Director) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Paid exercise price by delivering 9,304 shares
@ $8.77, valued at
$81.6k
Exercised 20,000 options
@ $4.08, valued at
$81.6k
|
|
| 08/01/2022 |
4
| Rozov Yadin (Director) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 12,000 shares
@ $0 |
|
| 08/01/2022 |
4
| Mayer Arie (Director) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 12,000 shares
@ $0 |
|
| 08/01/2022 |
4
| Derovan Netanel (Chief Legal Officer) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 30,000 shares
@ $0 |
|
| 08/01/2022 |
4
| Kidron Miriam (Chief Scientific Officer) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 34,000 shares
@ $0
Granted 84,000 shares
@ $0 |
|
| 08/01/2022 |
4
| KIDRON NADAV (President and CEO) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 34,000 shares
@ $0
Granted 126,000 shares
@ $0
Paid exercise price by delivering 12,631 shares
@ $8.36, valued at
$105.6k
|
|
| 08/01/2022 |
4
| Hexter Joshua (COO & CBO) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 42,000 shares
@ $0 |
|
| 08/01/2022 |
4
| Sank Leonard (Director) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 12,000 shares
@ $0 |
|
| 08/01/2022 |
4
| Silberman David (CFO) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 39,000 shares
@ $0 |
|
| 08/01/2022 |
4
| Rabinowitz Michael (Chief Commercial Officer) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 30,000 shares
@ $0 |
|
| 05/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2022 |
4
| RAKIN KEVIN (Director) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Sold 10,000 shares
@ $9.4096, valued at
$94.1k
|
|
|
|
|